These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3146890

  • 1. Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine.
    Nolen WA, van de Putte JJ, Dijken WA, Kamp JS, Blansjaar BA, Kramer HJ, Haffmans J.
    Acta Psychiatr Scand; 1988 Dec; 78(6):668-75. PubMed ID: 3146890
    [Abstract] [Full Text] [Related]

  • 2. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
    Emrich HM, Berger M, Riemann D, von Zerssen D.
    Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
    [Abstract] [Full Text] [Related]

  • 3. Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
    Kasper S, Voll G, Vieira A, Kick H.
    Pharmacopsychiatry; 1990 May; 23(3):135-42. PubMed ID: 2115680
    [Abstract] [Full Text] [Related]

  • 4. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline.
    Den Boer JA, Westenberg HG.
    Int Clin Psychopharmacol; 1988 Jan; 3(1):59-74. PubMed ID: 2833543
    [Abstract] [Full Text] [Related]

  • 5. Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine.
    Nolen WA, van de Putte JJ, Dijken WA, Kamp JS, Blansjaar BA, Kramer HJ, Haffmans J.
    Acta Psychiatr Scand; 1988 Dec; 78(6):676-83. PubMed ID: 3146891
    [Abstract] [Full Text] [Related]

  • 6. L-5HTP in depression resistant to re-uptake inhibitors. An open comparative study with tranylcypromine.
    Nolen WA, van de Putte JJ, Dijken WA, Kamp JS.
    Br J Psychiatry; 1985 Jul; 147():16-22. PubMed ID: 3933601
    [Abstract] [Full Text] [Related]

  • 7. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M, Binz U, Wendt G, Metzger R, Hole G.
    Neuropsychobiology; 1987 Jul; 17(1-2):41-8. PubMed ID: 3306439
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of fluvoxamine in treatment-refractory depression.
    Delgado PL, Price LH, Charney DS, Heninger GR.
    J Affect Disord; 1988 Jul; 15(1):55-60. PubMed ID: 2970493
    [Abstract] [Full Text] [Related]

  • 9. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K, Wykoff W, Tynes LL, Schneider L, Zemansky M.
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [Abstract] [Full Text] [Related]

  • 10. Long term treatment with oxaprotiline in patients with major depression.
    Katz RJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989 Sep; 13(6):875-83. PubMed ID: 2813805
    [Abstract] [Full Text] [Related]

  • 11. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
    Schmauss M, Laakmann G, Dieterle D, Blaschke D.
    Pharmacopsychiatry; 1985 Jul; 18(4):282-5. PubMed ID: 3895255
    [Abstract] [Full Text] [Related]

  • 12. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS.
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic effect of maprotiline and chlorimipramine: controlled study.
    Montejo-Iglesias ML, Ramos-Brieva JA.
    Neuropsychobiology; 1988 Jun; 19(1):20-4. PubMed ID: 3054622
    [Abstract] [Full Text] [Related]

  • 14. A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes.
    Eberhard G, von Knorring L, Nilsson HL, Sundequist U, Björling G, Linder H, Svärd KO, Tysk L.
    Neuropsychobiology; 1988 Jun; 19(1):25-34. PubMed ID: 3054623
    [Abstract] [Full Text] [Related]

  • 15. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
    de Jonghe F, Swinkels J, Tuynman-Qua H.
    Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.
    Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS.
    Arch Gen Psychiatry; 1989 Jan; 46(1):36-44. PubMed ID: 2491940
    [Abstract] [Full Text] [Related]

  • 17. Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects.
    Kasper S, Dötsch M, Kick H, Vieira A, Möller HJ.
    Eur Neuropsychopharmacol; 1993 Mar; 3(1):13-21. PubMed ID: 8471827
    [Abstract] [Full Text] [Related]

  • 18. Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.
    Schatzberg AF, Dessain E, O'Neil P, Katz DL, Cole JO.
    J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):44S-49S. PubMed ID: 3123528
    [Abstract] [Full Text] [Related]

  • 19. Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.
    Giedke H, Gaertner H, Breyer-Pfaff U, Rein W, Axmann D.
    Eur Arch Psychiatry Neurol Sci; 1986 Dec; 235(6):329-38. PubMed ID: 3527706
    [Abstract] [Full Text] [Related]

  • 20. Augmentation with fluvoxamine but not maprotiline improves negative symptoms in treated schizophrenia: evidence for a specific serotonergic effect from a double-blind study.
    Silver H, Shmugliakov N.
    J Clin Psychopharmacol; 1998 Jun; 18(3):208-11. PubMed ID: 9617979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.